Last reviewed · How we verify
ESTROGENS, ESTERIFIED
At a glance
| Generic name | ESTROGENS, ESTERIFIED |
|---|---|
| Phase | FDA-approved |
| First approval | 1977 |
Approved indications
Common side effects
Key clinical trials
- Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction (PHASE4)
- Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women (PHASE2)
- High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy (PHASE2)
- Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes (PHASE2)
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women (PHASE2)
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ESTROGENS, ESTERIFIED CI brief — competitive landscape report
- ESTROGENS, ESTERIFIED updates RSS · CI watch RSS